CEACAM5 and cholangiocarcinoma: A recent study found that preoperative serum CEA and CA19-9 levels can predict the resectability of cholangiocarcinoma6, while another found that elevated serum CEA and CA19-9 levels were associated with moderate sensitivity, true negativity rates and accuracy for the diagnosis of cholangiocarcinoma.7